Cancer risks after diagnostic doses of 131I with special reference to thyroid cancer
- Department of Cancer Prevention, Karolinska Institute and Hospital, Stockholm (Sweden)
Between 1951 and 1969 a total of 35,074 patients less than 75 years of age (mean = 44 years) were examined with diagnostic doses of 131I. The mean administered activity of 131I was 52 microCi and the radiation dose to the thyroid gland was on the average of 0.5 Gy. The cohort was matched with the Swedish Cancer Register for the years 1958-1984. During this period, 3746 cancers occurred more than 5 years after the 131I examination, and the resulting standardized incidence ratio (SIR) was 1.01 (95% confidence interval (CI) = 0.98 to 1.04). SIR for thyroid cancer was 1.18 (95% CI = 0.88 to 1.56). The risks for both cancer of all sites and for thyroid cancer were highest 5 to 9 years after examination (SIR = 1.07 and 2.06, respectively) and did not differ from unity thereafter. With greater than or equal to 10 years of follow-up, risk was not statistically associated with the dose of 131I.
- OSTI ID:
- 5552884
- Journal Information:
- Cancer Detection and Prevention; (United States), Vol. 15:1; ISSN 0361-090X
- Country of Publication:
- United States
- Language:
- English
Similar Records
Thyroid cancer after diagnostic doses of iodine-131: a retrospective cohort study
Cancer risk after iodine-131 therapy for hyperthyroidism
Related Subjects
IODINE 131
CARCINOGENESIS
NEOPLASMS
RADIOINDUCTION
THYROID
RADIATION DOSES
RISK ASSESSMENT
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BODY
DAYS LIVING RADIOISOTOPES
DISEASES
DOSES
ENDOCRINE GLANDS
GLANDS
INTERMEDIATE MASS NUCLEI
IODINE ISOTOPES
ISOTOPES
NUCLEI
ODD-EVEN NUCLEI
ORGANS
PATHOGENESIS
RADIOISOTOPES
560161* - Radionuclide Effects
Kinetics
& Toxicology- Man